Related Experiment Video
Updated: Aug 8, 2026
08:29
Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
Stochastic cancer progression driven by non-clonal chromosome aberrations
Henry H Q Heng1, Joshua B Stevens, Gou Liu
1Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI 48201, USA. hheng@med.wayne.edu
Journal of Cellular Physiology
|May 12, 2006
Summary
Genomic instability, not just gene mutations, drives cancer by causing random chromosomal changes. Non-clonal chromosomal aberrations (NCCAs) are key to cancer progression and diversity.
Area of Science:
- Genetics
- Cancer Biology
- Genomics
Background:
- Traditional cancer research focused on stepwise genetic aberrations.
- This model conflicts with observed tumor genetic heterogeneity and karyotypes.
- Tumorigenesis is complex, involving more than just gene accumulation.
Purpose of the Study:
- To investigate the role of chromosomal instability in cancer progression.
- To determine if non-clonal chromosomal aberrations (NCCAs) drive cancer evolution.
- To understand the interplay between NCCAs and clonal chromosomal aberrations (CCAs).
Main Methods:
- Tracing karyotypic patterns in cells with compromised genome integrity.
- Challenging cells with oncoproteins or carcinogens to induce genomic instability.
- Analyzing karyotypic evolution during cellular immortalization stages.
Main Results:
- Genomic instability generates stochastic karyotypic changes, driving random cancer progression.
- Non-clonal chromosomal aberrations (NCCAs) are directly linked to genomic instability and karyotypic evolution, not recurrent clonal aberrations (CCAs).
- Transitional CCAs indicate that karyotypic evolution in solid tumors is not continuous.
Conclusions:
- Genomic instability and NCCAs are primary drivers of cancer progression.
- The dynamic interplay between NCCAs and CCAs generates genomic combinations for cancer cell evolution.
- This chromosomal aberration mechanism offers potential clinical applications in cancer treatment.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...